Filing Details

Accession Number:
0001764013-23-000156
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-05 16:30:51
Reporting Period:
2023-12-01
Accepted Time:
2023-12-05 16:30:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1764013 Immunovant Inc. IMVT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1341896 J. Andrew Fromkin 320 W 37Th Street, 6Th Floor
New York NY 10018
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-12-01 3,941 $38.78 97,067 No 4 S Direct
Common Stock Disposition 2023-12-01 3,636 $39.81 93,431 No 4 S Direct
Common Stock Disposition 2023-12-01 4,773 $40.46 88,658 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents the sale of shares of common stock pursuant to a Rule 10b5-1 trading plan adopted on May 24, 2023, in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the above award of restricted stock covering shares of common stock and does not represent a discretionary sale by the reporting person.
  2. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.19 - $39.13 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
  3. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $39.22 - $40.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
  4. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.24 - $40.60 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.